The role of Toll -like receptor 4 for peritonitis and peritoneal fibrosis in CAPD patients

Not Applicable

• Conditions: end- stage renal disease; diseases

• Registration Number: TCTR20151113002
• Lead Sponsor: chen xiao xue

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-11-13
• Study Completion: 2017-11-02
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

peritonitis or peritoneal fibrosis in CAPD patients whose peritoneal dialysis duration is more than 3 months

Exclusion Criteria

1.CAPD patients whose peritoneal dialysis duration less than 3 months
2.CAPD patients who suffer from primary peritonitis
3.CAPD patients who suffer from peritonitis secondary to abdominal trauma or intra-abdominal infection etc.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
TLR4mRNA 2 years R-TPCR western-blot

Secondary Outcome Measures

Name	Time	Method
IL-6 IL-8 TGFβ1collagenI 2 years Elisa